Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | |
|---|---|---|---|---|---|---|
| Turnover | -37.02%252.43M | 36.22%716.64M | --400.81M | 45.65%526.1M | -30.58%361.21M | --520.35M |
| Operating income | -37.02%252.43M | 36.22%716.64M | 400.81M | 45.65%526.1M | -30.58%361.21M | 520.35M |
| Cost of sales | 37.52%-200.28M | -41.47%-572.23M | ---320.54M | -41.59%-404.49M | 33.06%-285.67M | ---426.74M |
| Operating expenses | 37.52%-200.28M | -41.47%-572.23M | -320.54M | -41.59%-404.49M | 33.06%-285.67M | -426.74M |
| Gross profit | -35.04%52.15M | 18.75%144.41M | 80.28M | 61.00%121.61M | -19.31%75.53M | 93.61M |
| Selling expenses | ---4.1M | ---- | ---- | ---- | ---- | ---- |
| Administrative expenses | -11.46%-22.88M | -157.17%-60.59M | ---20.53M | -3.22%-23.56M | -12.12%-22.83M | ---20.36M |
| Impairment and provision | -136.96%-445K | 260.92%628K | --1.2M | 102.01%174K | -172.07%-8.64M | ---3.18M |
| -Other impairment is provision | -136.96%-445K | 260.92%628K | --1.2M | 102.01%174K | -172.07%-8.64M | ---3.18M |
| Special items of operating profit | 102.64%330K | -373.75%-13.91M | ---12.49M | -153.42%-2.94M | 211.15%5.5M | --1.77M |
| Operating profit | -48.30%25.06M | -25.98%70.53M | 48.47M | 92.25%95.28M | -31.01%49.56M | 71.84M |
| Financing cost | -30.40%-1.93M | 3.89%-2.28M | ---1.48M | -23.54%-2.37M | -43.63%-1.92M | ---1.33M |
| Earning before tax | -50.78%23.13M | -26.54%68.25M | 46.99M | 95.01%92.92M | -32.43%47.65M | 70.51M |
| Tax | 58.52%-3.92M | 20.08%-12.8M | ---9.45M | -126.05%-16.01M | 38.18%-7.08M | ---11.46M |
| After-tax profit from continuing operations | -48.83%19.21M | -27.89%55.46M | 37.54M | 89.59%76.91M | -31.31%40.57M | 59.06M |
| Earning after tax | -48.83%19.21M | -27.89%55.46M | 37.54M | 89.59%76.91M | -31.31%40.57M | 59.06M |
| Minority profit | ---- | ---- | ---- | ---- | -93.49%39K | --599K |
| Profit attributable to shareholders | -48.83%19.21M | -27.89%55.46M | 37.54M | 89.77%76.91M | -30.67%40.53M | 58.46M |
| Basic earnings per share | -60.00%0.02 | -37.86%0.064 | 0.05 | 0.103 | ||
| Diluted earnings per share | -60.00%0.02 | -37.86%0.064 | 0.05 | 0.103 | ||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PwC Accounting Firm | PwC Accounting Firm | PwC Accounting Firm |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.